Table 11.
| ||||||
|---|---|---|---|---|---|---|
| Compound | R1 | R2 | R3 | U-937 72h IC50 (μM) | RLM 3h %Stability | Mouse Toxicity IP 200 mg/kg (* = 100 mg/kg) |
| PAC-1 (1) | Bn | H | All | 10.2 ± 0.3 | 38 ± 2 | Severe |
| 14a | 4-F-Bn | H | All | 11.1 ± 2.1 | 31 ± 1 | N.D. |
| S-PAC-1 (37) | 4-SO2NH2-Bn | H | All | 8.9 ± 0.6 | 84 ± 1 | None |
| 38 | Bz | H | All | 12.1 ± 1.3 | 89 ± 4 | N.D. |
| 39 | 4-CN-Bn | H | All | 13.7 ± 0.9 | 48 ± 2 | N.D. |
| 40 | 4-CN-Bz | H | All | 13.1 ± 3.7 | 90 ± 4 | N.D. |
| 41 | 4-F-Bz | H | All | 10.2 ± 1.7 | 86 ± 2 | Moderate |
| 42 | 4-CF3-Bn | H | All | 15.3 ± 6.7 | 16 ± 1 | N.D. |
| 43 | 4-CF3-Bz | H | All | 6.6 ± 1.9 | 85 ± 6 | Lethal* |
| 44 | Bn | H | n-Pr | 9.6 ± 2.1 | 30 ± 1 | N.D. |
| 45 | 4-SO2NH2-Bn | H | n-Pr | 4.9 ± 0.4 | 61 ± 2 | N.D. |
| 46 | Bz | H | n-Pr | 9.4 ± 1.3 | 71 ± 3 | N.D. |
| 47 | 4-CN-Bn | H | n-Pr | 9.0 ± 1.2 | 30 ± 2 | N.D. |
| 48 | 4-CN-Bz | H | n-Pr | 12.8 ± 2.7 | 61 ± 3 | N.D. |
| 49 | 4-F-Bn | H | n-Pr | 10.0 ± 1.7 | 24 ± 2 | N.D. |
| 50 | 4-F-Bz | H | n-Pr | 7.3 ± 0.9 | 69 ± 4 | N.D. |
| 51 | 4-CF3-Bn | H | n-Pr | 4.1 ± 0.4 | 15 ± 2 | N.D. |
| 52 | 4-CF3-Bz | H | n-Pr | 4.8 ± 1.2 | 64 ± 1 | Lethal* |
| 53 | Bn | F | H | 17.0 ± 1.4 | 64 ± 4 | N.D. |
| 54 | 4-SO2NH2-Bn | F | H | N.D. | N.D. | N.D. |
| 55 | Bz | F | H | 15.7 ± 2.6 | 88 ± 1 | N.D. |
| 56 | 4-CN-Bn | F | H | N.D. | N.D. | N.D. |
| 57 | 4-CN-Bz | F | H | 15.3 ± 1.3 | 88 ± 4 | N.D. |
| 58 | 4-F-Bn | F | H | N.D. | N.D. | N.D. |
| 59 | 4-F-Bz | F | H | 15.3 ± 0.8 | 86 ± 2 | N.D. |
| 60 | 4-CF3-Bn | F | H | 4.7 ± 0.3 | 30 ± 5 | N.D. |
| 61 | 4-CF3-Bz | F | H | 8.7 ± 0.5 | 87 ± 3 | Moderate |
| 62 | Bn | F | All | 9.5 ± 0.9 | 56 ± 1 | N.D. |
| 63 | 4-SO2NH2-Bn | F | All | 9.8 ± 1.3 | 89 ± 3 | Lethal |
| 64 | Bz | F | All | 8.6 ± 2.0 | 93 ± 7 | Moderate |
| 65 | 4-CN-Bn | F | All | 12.7 ± 2.0 | 65 ± 2 | N.D. |
| 66 | 4-CN-Bz | F | All | 10.1 ± 2.0 | 95 ± 4 | Mild |
| 67 | 4-F-Bn | F | All | 10.3 ± 4.1 | 57 ± 1 | N.D. |
| 68 | 4-F-Bz | F | All | 8.5 ± 1.4 | 92 ± 3 | Severe |
| 69 | 4-CF3-Bn | F | All | 3.4 ± 0.6 | 49 ± 3 | N.D. |
| 70 | 4-CF3-Bz | F | All | 6.5 ± 0.6 | 90 ± 2 | Moderate |
| 71 | Bn | F | n-Pr | 8.9 ± 1.2 | 49 ± 6 | N.D. |
| 72 | 4-SO2NH2-Bn | F | n-Pr | 8.7 ± 0.4 | 62 ± 3 | N.D. |
| 73 | Bz | F | n-Pr | 12.3 ± 1.0 | 86 ± 5 | N.D. |
| 74 | 4-CN-Bn | F | n-Pr | 11.2 ± 0.9 | 49 ± 5 | N.D. |
| 75 | 4-CN-Bz | F | n-Pr | 9.4 ± 1.2 | 66 ± 3 | Mild |
| 76 | 4-F-Bn | F | n-Pr | 7.5 ± 0.7 | 48 ± 1 | N.D. |
| 77 | 4-F-Bz | F | n-Pr | 7.5 ± 1.4 | 67 ± 3 | Severe |
| 78 | 4-CF3-Bn | F | n-Pr | 3.9 ± 0.6 | 40 ± 1 | N.D. |
| 79 | 4-CF3-Bz | F | n-Pr | 5.2 ± 0.6 | 64 ± 5 | Lethal |
N.D. = not determined.
Cells treated with compounds for 72 hours. Biomass quantified by sulforhodamine B assay. IC50 values shown are mean ± s.e.m. (n = 3).
Rat liver microsomes treated with compounds (10 μM) for 3 hours. Percent stability values shown are mean ± s.e.m. (n = 3).
Mice dosed with compound via i.p. injection at 200 mg/kg (except *100 mg/kg). [50]